Possible Drug–Herb Interaction between Herbal Supplement Containing Horsetail (Equisetum arvense) and Antiretroviral Drugs

The use of alternative medicines, including herbs, is common among HIV-positive patients, even in those on antiretroviral treatment. Equisetum arvense, known as “horsetail,” is mainly used for its diuretic properties. There are limited data about the pharmacological properties of this compound and the potential drug–herb interactions. The authors report 2 cases in which a possible drug–herb interaction may have led to virological breakthrough in patients who were maintained on the same regimen for many years, including lamivudine (3TC)/zidovudine (ZDV)/efavirenz (EFV) and emtricitabine (FTC)/tenofovir (TDF)/EFV, respectively. Therefore, a drug–herb interaction may be expected when these agents are taken concurrently. Until additional data are available, the authors advise clinicians to avoid this combination when possible.

[1]  O. G. Nilsen,et al.  In vitro Inhibition of Human CYP1A2, CYP2D6, and CYP3A4 by Six Herbs Commonly Used in Pregnancy , 2014, Phytotherapy research : PTR.

[2]  P. Fasinu,et al.  An Overview of the Evidence and Mechanisms of Herb–Drug Interactions , 2012, Front. Pharmacol..

[3]  B. Clotet,et al.  [Use of herbal remedies among HIV-infected patients: patterns and correlates]. , 2012, Medicina clinica.

[4]  J. Moltó,et al.  Consumo de plantas medicinales en los pacientes infectados por el virus de la inmunodeficiencia humana. Patrones de uso y factores relacionados , 2012 .

[5]  K. Gough,et al.  A Potential Drug–Herbal Interaction between Ginkgo biloba and Efavirenz , 2012, Journal of the International Association of Physicians in AIDS Care.

[6]  V. Křen,et al.  The effects of selected flavonoids on cytochromes P450 in rat liver and small intestine , 2009, Interdisciplinary toxicology.

[7]  K. Brinkman,et al.  Interaction of Ginkgo biloba with efavirenz. , 2009, AIDS.

[8]  N. Mimica-Dukić,et al.  Phenolic Compounds in Field Horsetail (Equisetum arvense L.) as Natural Antioxidants , 2008, Molecules.

[9]  John R Horn,et al.  Proposal for a New Tool to Evaluate Drug Interaction Cases , 2007, The Annals of pharmacotherapy.

[10]  R. Hogg,et al.  Complementary and alternative medicine use in British Columbia--a survey of HIV positive people on antiretroviral therapy. , 2006, Complementary therapies in clinical practice.

[11]  A. J. van der Ven,et al.  Possible Drug–Metabolism Interactions of Medicinal Herbs with Antiretroviral Agents , 2006, Drug metabolism reviews.

[12]  J. Rivera,et al.  Herbal product use in non-HIV and HIV-positive Hispanic patients. , 2005, Journal of the National Medical Association.

[13]  David A. Flockhart,et al.  The Cytochrome P450 2B6 (CYP2B6) Is the Main Catalyst of Efavirenz Primary and Secondary Metabolism: Implication for HIV/AIDS Therapy and Utility of Efavirenz as a Substrate Marker of CYP2B6 Catalytic Activity , 2003, Journal of Pharmacology and Experimental Therapeutics.

[14]  L. Liberti,et al.  Natural product medicine: A scientific guide to foods, drugs, cosmetics , 1988 .